Statera Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	0	74	-	-	-
Market Cap Growth	-89.04%	-	-	-	-
Enterprise Value	7	81	-	-	-
Last Close Price	0.00	2.30	-	-	-
PE Ratio	-	-0.79	-	-	-
PS Ratio	0.01	49.64	-	-	-
PB Ratio	-0.64	-48.99	-	-	-
P/FCF Ratio	-0.53	-2.60	-	-	-
P/OCF Ratio	-0.54	-2.62	-	-	-
EV/Sales Ratio	1.88	54.72	-	-	-
EV/EBITDA Ratio	0.15	-2.63	-	-	-
EV/EBIT Ratio	0.15	-2.61	-	-	-
EV/FCF Ratio	-1.15	-2.87	-	-	-
Debt / Equity Ratio	-0.73	-10.79	-0.55	-0.43	-0.55
Debt / FCF Ratio	-0.61	-0.57	-0.39	-7.51	-0.37
Asset Turnover	0.07	0.13	-	-	-
Quick Ratio	0.04	0.21	0.20	0.00	0.00
Current Ratio	0.05	0.37	0.20	0.00	0.13
Return on Equity (ROE)	-286.94%	-	-	-	-
Return on Assets (ROA)	-23.85%	-175.85%	-1229.55%	-877.33%	-
Return on Capital (ROIC)	-29.90%	-298.03%	-	-	-
Earnings Yield	-222698.98%	-137.97%	-	-	-
FCF Yield	-30254.32%	-38.44%	-	-	-
Buyback Yield / Dilution	-85.80%	-381.26%	62.79%	-14.67%	-
Total Shareholder Return	-85.80%	-381.26%	62.79%	-14.67%	-

Source: S&P Capital IQ. Standard template.